• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

我们应该如何在保持和平与安全环境的同时扩大迷幻药的使用?

How Should We Expand Access to Psychedelics While Maintaining an Environment of Peace and Safety?

机构信息

Fourth-year medical student at Columbia Vagelos College of Physicians and Surgeons in New York City.

Assistant professor of psychiatry at Columbia University Irving Medical Center in New York City.

出版信息

AMA J Ethics. 2024 Nov 1;26(11):E868-874. doi: 10.1001/amajethics.2024.868.

DOI:10.1001/amajethics.2024.868
PMID:39495644
Abstract

Psychedelics have long been used by individuals seeking peace and a sense of wellness. This article examines widespread adoption of ketamine as a proxy for psychedelics. For ketamine, there is a need to protect vulnerable persons from exploitation that should be balanced against risks of hypermedicalization. This article suggests strategies for striking such a balance, including by carefully differentiating between persons with psychiatric illnesses, such as treatment-resistant depression, who could benefit from psychedelics, and persons using psychedelics for peace and wellness under careful guidance.

摘要

迷幻剂长期以来一直被寻求平静和健康感的个人使用。本文探讨了广泛采用氯胺酮作为迷幻剂的替代物的现象。对于氯胺酮,需要保护弱势群体免受剥削,同时要平衡过度医疗化的风险。本文提出了一些策略来平衡这两者,包括仔细区分那些患有精神疾病(如抗抑郁治疗抵抗)的人和那些在谨慎指导下使用迷幻剂寻求平静和健康感的人。

相似文献

1
How Should We Expand Access to Psychedelics While Maintaining an Environment of Peace and Safety?我们应该如何在保持和平与安全环境的同时扩大迷幻药的使用?
AMA J Ethics. 2024 Nov 1;26(11):E868-874. doi: 10.1001/amajethics.2024.868.
2
Role of Psychedelics in Treatment-Resistant Depression.迷幻药在治疗抵抗性抑郁症中的作用。
Psychiatr Clin North Am. 2023 Jun;46(2):291-305. doi: 10.1016/j.psc.2023.02.004. Epub 2023 Mar 25.
3
Efficacy, Safety, and Tolerability of Psychedelics in Treatment-Resistant Depression (TRD).抗抑郁治疗抵抗性抑郁症(TRD)中使用致幻剂的疗效、安全性和耐受性。
Adv Exp Med Biol. 2024;1456:49-66. doi: 10.1007/978-981-97-4402-2_3.
4
Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.健康志愿者、重度抑郁症和治疗抵抗性抑郁症患者中裸盖菇素、麦角酸二乙基酰胺(LSD)和氯胺酮的光谱特征:系统评价。
J Affect Disord. 2024 Jun 15;355:342-354. doi: 10.1016/j.jad.2024.03.165. Epub 2024 Apr 1.
5
[Clinical management of treatment-resistant depression].[难治性抑郁症的临床管理]
Nervenarzt. 2024 May;95(5):416-422. doi: 10.1007/s00115-024-01647-z. Epub 2024 Apr 3.
6
Psychedelics in the treatment of unipolar mood disorders: a systematic review.迷幻剂治疗单相情绪障碍:一项系统综述。
J Psychopharmacol. 2016 Dec;30(12):1220-1229. doi: 10.1177/0269881116679368. Epub 2016 Nov 17.
7
Psychedelics and ketamine are a symptom of psychiatry's woes, not a cure.迷幻剂和氯胺酮是精神病学困境的一种症状,而非治疗方法。
Mol Psychiatry. 2023 Aug;28(8):3167-3168. doi: 10.1038/s41380-023-02132-w. Epub 2023 Jun 23.
8
[Ketamine infusion therapy in treatment-resistant depression].[氯胺酮输注疗法治疗难治性抑郁症]
Psychiatriki. 2021 Dec;32(Supplement I):64-69. doi: 10.22365/jpsych.2021.051.
9
Past Is Prologue: Ethical Issues in Pediatric Psychedelics Research and Treatment.过去即是序幕:儿科迷幻药物研究与治疗中的伦理问题。
Perspect Biol Med. 2023;66(1):129-144. doi: 10.1353/pbm.2023.0007.
10
Taking Psychedelics Seriously.认真对待迷幻药。
J Palliat Med. 2018 Apr;21(4):417-421. doi: 10.1089/jpm.2017.0684. Epub 2018 Jan 22.